Emergent BioSolutions
EBS | NYSE
$5.81
+$0.02 (+0.43%)
At close: Nov 16, 2026, 4:00 PM ET
$5.94
+$0.13 (+2.24%)
After-hours:
Nov 16, 2026, 6:11 PM ET
+0.43%
(1D)No price chart data available for 1D timeframe.
Rating
35.5
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #632/1021 (Top 62%)
Key Statistics
Market Data
Market Cap $298.72M
1D Range
5.70 5.87
52W Range
4.45 13.90
Valuation (TTM)
PE -1.30
PB 0.95
EV/EBITDA -6.51
Valuation (NTM)
Forward PE 19.97
Forward PEG 0.01
Price Target $10.00
Cash Flow
FCF Yield 63.1%
SBC Adj. FCF Yield 56.9%
SBC Impact -9.7%
Margins
Gross Margin 41.6%
Operating Margin -26.0%
FCF Margin 29.0%
Growth (CAGR)
Revenue 3Y | 5Y -16.2% |
-17.1%
Dil EPS 3Y | 5Y -7.4% |
14.7%
FCF 3Y | 5Y 23.0% |
52.4%
Returns
ROA -26.2%
ROE -61.3%
ROIC -19.3%
Financial Health
Net Debt
$332M
Current Ratio 4.58
Interest Coverage -3.71
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These ...
Sector Healthcare
Employees 900
IPO Date Nov 15, 2006
Website www.emergentbiosolutions.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 2, 2026
EPS
-$0.36
Beat +8.03%
YoY:
-133.96% REV
$110M
Miss -10.73%
YoY:
-52.40%Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$10.00
Upside
+72.12%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove EBS